Cyclerion Therapeutics, Inc. (CYCN) — DEF 14A Filings
All DEF 14A filings from Cyclerion Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Cyclerion Therapeutics Files Definitive Proxy Statement
— Apr 29, 2025 Risk: low
Cyclerion Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 29, 2025, for its annual meeting on June 16, 2025. The filing concerns the -
Cyclerion Therapeutics, Inc. Announces Annual Meeting of Shareholders on June 14, 2024
— Apr 29, 2024 Risk:
Cyclerion Therapeutics, Inc. (CYCN) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. Cyclerion Therapeutics, Inc. will hold its Annual Meeting
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX